Listen to our podcast, "Visits with Vanessa," to learn more about home hemodialysis (HHD). Vanessa Evans, Senior Manager of Patient Advocacy, will invite patients, care partners, and healthcare experts to talk about the dialysis journey, how HHD has impacted their lives, and many other important therapy related topics. Special guests will share their experiences, tips, and more.
Patient Advocate Dawn tells us all about her and husband Jimmie’s 3-month RV road trip. Hear the details about how they were able to leave home for 3 months without skipping a beat in Jimmie’s HHD treatments.
Nieltje, a home hemodialysis patient and NxStage user, joins us to discuss balancing it all and staying positive. Nieltje knew she needed to have treatment schedule flexibility and independence in order to make dialysis treatments work in her life.
Dawn, a home hemodialysis (HHD) patient and Patient Advocate, lives in a smaller space and makes dialysis work for her. See how she manages her supplies and gets creative with storage for successful home therapy.
Maaya, a Patient Advocate, lost her kidney function in 2014. With a busy career and family life, Maaya found that traditional in-center dialysis wasn’t the right fit for her lifestyle and transitioned to home hemodialysis, freeing up more time for what’s important to her.
The second episode of our patient-centered home hemodialysis (HHD) focused podcast, Visits with Vanessa, is available now. Our special guest, Dawn, is a NxStage Patient Advocate, nocturnal home hemodialysis (HHD) patient, and a NxStage user. Vanessa and Dawn will discuss a variety of HHD options—more frequent HHD with a care partner, solo/independent HHD, nocturnal HHD—as well as portability and travel. Tune in to understand what HHD options are available and get more information to make the choice that's best for you.
Hear about traveling with the NxStage Home Hemodialysis (HHD) system from Dawn Bates, NxStage Patient Advocate, and care partner for her husband Jimmie. Jimmie has been on HHD for 12 years and has successfully integrated home therapy into his lifestyle. Dawn and Vanessa share tips and tricks on traveling by car and by plane with the NxStage system. Our host, Vanessa, is an avid traveler and has taken almost 30 trips with her HHD machine in the last five years!
Vanessa lives in Boston with her husband and two sons. She has been on dialysis for more than 22 years and and has been a passionate advocate in the kidney community for the last 14 years. Vanessa serves as Senior Manager of Patient Advocacy for Fresenius Medical Care North America and is a member of the Kidney Health Initiative’s Patient and Family Partnership Council. She holds a master’s degree from Emerson College and a BA in Political Science from University of Massachusetts Amherst. As part of her patient advocacy work, she partners with the National Kidney Foundation, Patient Centered Outcomes Research Institute, the American Association of Kidney Patients, and other organizations.
*Paid Speaker †NxStage employee
Risk and Responsibility
Patients should review the following information carefully and discuss it with their doctors to decide whether home hemodialysis with NxStage systems is right for them.
Users should weigh the risks and benefits of performing home hemodialysis with NxStage systems.
Medical staff will not be present to respond to health emergencies that might happen during home treatments, including, among other things, dizziness, nausea, low blood pressure, and fluid or blood leaks.
Users may not experience the reported benefits of home, more frequent, or nocturnal hemodialysis with the NxStage systems.
The NxStage systems require a prescription for use.
Users will be responsible for all aspects of their hemodialysis treatment from start to finish.
Medical staff will not be present to perform home treatments. Users will be responsible for, among other things, equipment setup, needle insertions, responding to and resolving system alarms, system tear-down after treatment, monitoring blood pressure, ensuring proper aseptic technique is followed, and following all the training material and instructions that nurses provide.
Users will need additional resources to perform home hemodialysis.
Users will need a trained care partner to be present during your treatment at home (unless their doctor prescribes “solo/independent” home hemodialysis, described below).
Users must have a clean and safe environment for their home treatments.
Users will need space in their home for boxes of supplies necessary to perform home hemodialysis with NxStage systems.
Certain forms of home hemodialysis have additional risks.
If a doctor prescribes home hemodialysis more than 3 times a week, vascular access is exposed to more frequent use which may lead to access related complications, including infection of the site. Doctors should evaluate the medical necessity of more frequent treatments and discuss the risks and benefits of more frequent therapy with users.
If a doctor prescribes “solo/independent” home hemodialysis without a care partner during waking hours, risks of significant injury or death increase because no one is present to help users respond to health emergencies. If users experience needles coming out, blood loss, or very low blood pressure during solo/independent home hemodialysis, they may lose consciousness or become physically unable to correct the health emergency. Users will need additional ancillary devices and training to perform solo/independent home hemodialysis.
If a doctor prescribes “nocturnal” home hemodialysis at night while the user and a care partner are sleeping, risks increase due to the length of treatment time and because therapy is performed while the user and a care partner are sleeping. These risks include, among other things, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep. A doctor may need to adjust users’ medications for nocturnal home hemodialysis, including, among other things, iron, Erythropoiesis-Stimulating Agents (ESA), insulin/oral hypoglycemics, anticoagulants, and phosphate binders.
Fresenius Medical Care has successfully completed its merger with NxStage Medical, Inc.
Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. For information about NxStage products and services please continue to use this website. To learn more about Fresenius Medical Care and the merger, visit the links provided.